Categories: India

UPDATE 1-Vaxcyte shares surge as pneumococcal vaccine succeeds in late-stage trial

(Updates shares in paragraph 1, adds analysts' comment in bullets 5 and 8) By Siddhi Mahatole Oct 5 (Reuters) – Vaxcyte said on Monday its experimental pneumococcal vaccine generated immune responses

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

PETRONAS CEO SAYS FUEL MARKETS WILL BE BEDLAM FOR END OF YEAR AND MAYBE 2027 BECAUSE OF MIDEAST CRISIS

PETRONAS CEO SAYS FUEL MARKETS WILL BE BEDLAM FOR END OF YEAR AND MAYBE 2027…

2 minutes ago

Nvidia, Broadcom shielded as AI power crunch hits chip supply chain, says Morgan Stanley

Oct 5 (Reuters) - Nvidia and Broadcom are relatively insulated from a worsening US data-center…

3 minutes ago

Nvidia, Broadcom shielded as AI power crunch hits chip supply chain, says Morgan Stanley

Oct 5 (Reuters) - Nvidia and Broadcom are relatively insulated from a worsening US data-center…

4 minutes ago

SOFTS-Raw sugar tears through 20 cents/lb level, hits 19-month high

(Updates prices, adds details) LONDON, Oct 5 (Reuters) - Raw sugar futures on ICE surged…

9 minutes ago

Alcaraz fights back to set up Japan Open final with Lehecka

VIDEO SHOWS: HIGHLIGHTS OF THE ATP 500 JAPAN OPEN SEMIFINAL MATCHES BETWEEN - CARLOS ALCARAZ…

10 minutes ago

Secures Export Order from Canada for Approximately 5,000 MT of Black Welded Hollow Sections

Chandigarh [India], October 5: JTL Industries Limited (“JTL” or “the Company”) (BSE: 534600 | NSE:…

11 minutes ago